Feldan Therapeutics

Quebec, Canada · Founded 2007 · Privately Held (backing)

Operator of a peptide-based intracellular delivery platform designed to enable access to therapeutic targets within cells for the treatment of serious diseases. Feldan Therapeutics is based in Quebec, Canada and was founded in 2007. Its last known valuation is $40.3 million. It has raised $39.2 million.

Last price · $/share
—
Implied valuation
$40.3M
Total raised
$39.2M
Last round
—

Who backs Feldan Therapeutics?

14 investors
InvestorType
Investissement QuebecOther
Fonds de solidarite FTQOther
AQC Capital—
Amgen Ventures—
Anges Québec—
Asahi Kasei Corporate Venture Capital—
CCI—
Genesys Capital—
Green Cross Holdings—
Groupe Roski—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Feldan Therapeutics investors

14 investors are on record for Feldan Therapeutics, including Investissement Quebec, Fonds de solidarite FTQ, AQC Capital and Amgen Ventures.

Free account
More of Feldan Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch Feldan Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Feldan Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View